Scientific ReportsGenetic & Genomic MedicinePeer-reviewed journal article
Targeted Metagenomics Reveals Hidden Chickenpox Epidemic Amid Mpox Surveillance in Uganda
Stephen KanyereziiD, Alisen AyitewalaiD, Jupiter Marina KabahitaiD, Hellen Rosette OundoiD, Julius Sseruyange, Wilson Tenywa, Godwin TusabeiD, Stacy Were, Moses Murungi, Martha Nabukyu, Valeria NakintuiD, Caroline MakohaiD, Ivan SserwaddaiD, Harris OnyweraiD, Collins Kipngetich TanuiiD, Ibrahim MugerwaiD, Atek Atwiine KagiritaiD, Bernard Lubwama, Eilu Roggers MichaeliD, David Patrick KateeteiD, Morgan Otita, Samuel GiduduiD, Daudi JjingoiD, Andrew NsawotebbaiD, Gerald MboowaiD, , Isaac SsewanyanaiD
Abstract
In regions where both Mpox virus (MPXV) and varicella zoster virus (VZV) are co-circulating, overlapping clinical manifestations can complicate clinical diagnosis. During the MPXV outbreak declared in Uganda on July, 2024, symptomatic suspected cases tested PCR negative for Mpox. To determine the cause of symptoms, we employed metagenomic sequencing with a targeted Viral Surveillance panel in 284 Mpox negative samples. VZV was identified as the predominant pathogen in 86% of MPXV-negative cases, suggesting a concurrent chickenpox surge. Using the VaricellaGen pipeline for variant calling, clade typing, and phylogeny, 118 (42%) samples that achieved [≥]70% genome coverage were of clade 5 based on the single-nucleotide polymorphism (SNP) dataset. This data confirms co-circulation of chickenpox during the Mpox outbreak in Uganda. Our results underscore the need for laboratory confirmation of Mpox and the inclusion of VZV in the testing algorithm during the Mpox outbreak.
- organism: human
- assay: metagenomics
- research focus: variant calling
- research focus: phylogenetics / evolution
- approach: statistical model
- Citations
- 2
- FWCI
- 6.69
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genomic sequence analysis of the first mpox virus detected in Kenya
Solomon K. Langat, Konongoi Limbaso, … Elijah Maritim Songok·bioRxiv·Aug 20, 2024
- Emergence of mpox in Guinea: sporadic clade IIa cases and a clade IIb upsurge
Jacob Camara, Nils Peter Petersen, … Sanaba Boumbaly·bioRxiv·Mar 5, 2026
- Preliminary report on the molecular epidemiology of mpox, South Africa 2024
Jonathan Featherston, Antoinette A. Grobbelaar, … Jacqueline Weyer·bioRxiv·Nov 7, 2024
- High genetic diversity of mpox virus (MPXV) in three different rodent species in the Democratic Republic of the Congo (DRC)
Meris Matondo-Kuamfumu, Pascal Baelo, … Steve Ahuka Mundeke·bioRxiv·Aug 28, 2025
- Characterization of the cytopathic effect of monkeypox virus isolated from clinical specimens and differentiation from common viral exanthems
A. Ma, K. E. Hanson, … B. T. Bradley·bioRxiv·Sep 13, 2022
- Vaccinia virus vaccination is expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus
S. F. Ahmed, M. S. Sohail, … M. R. McKay·bioRxiv·Jun 23, 2022